Show
Sort by
-
Patenting time-lapse microscopy : the European story
-
Response : Stanford University's patent on embryo selection should be excluded under European patent law
-
The lack of access to medicines and the Health Impact Fund scheme
-
'I prefer a child with …' : designer babies, another controversial patent in the arena of direct-to-consumer genomics
-
- Journal Article
- A1
- open access
'Trust is not something you can reclaim easily' : patenting in the field of direct-to-consumer genetic testing
-
- Journal Article
- A2
- open access
Are products of essentially biological processes patentable in Europe? The purple radish case in The Netherlands
-
Ethics and patenting in Europe
-
Are natural products and diagnostic tests still eligible for patents in the US?
-
Exclusions from patentability : how far has the European Patent Office eroded boundaries?
(2012) -
- Journal Article
- A1
- open access
Is the enlarged board of appeal of the European patent office authorised to extend the bounds of the patentable? The G-3/85 second medical indication/EISAI and G-2/08 dosage regime/ABBOTT RESPIRATORY cases